MyFinsight
Home
Blog
About
Back
Income Statement
Alzamend Neuro, Inc. (ALZN)
Alzamend Neuro, Inc. (ALZN)
source: myfinsight.com
Net loss available
to common shares
-$8,772,382
Net loss
-$8,772,382
Loss from operations
-$8,766,841
Total other expense,
net
-$5,541
Interest income
$1,078
Total operating
expenses
$8,766,841
Interest expense
$6,619
General and
administrative
$5,137,056
Research and development
$3,629,785
Back